4th Quarter - Report

BOCKORNY GROUP, INC. for GENERIC PHARMACEUTICAL ASSOCIATION

Period 4th Quarter 2015 Filed Jan 20, 2016 Signed by David Bockorny

Official filing
Firm
BOCKORNY GROUP, INC.
Client
GENERIC PHARMACEUTICAL ASSOCIATION
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues Related to Global Health Negotiations as Part of the ongoing TPP Negotiations.

LobbyistCovered position, as disclosed
NICOLE VENABLE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Health Issues HCR

Drug Affordability and Access Issues 21st Century Cures Initiative and Related Legislative Proposals Advanced Medicines Initiative HR 2841, FAST Generics Act of 2015 (Fair Access for Safe and Timely Generics)

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
BLAIR C LARKINS —
BERNARD ROTHSCHILD —
NICOLE VENABLE —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 2841 (114th)

Budget/Appropriations BUD

Ag-appropriations language related to labeling issues

LobbyistCovered position, as disclosed
BLAIR C LARKINS —
NICOLE VENABLE —

Contacted: SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Pharmacy PHA

Issues Related to Biosimilar Regulation, Labeling, E-Labeling and Access

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
BLAIR C LARKINS —
BERNARD ROTHSCHILD —
NICOLE VENABLE —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.